- Home
- SWX vs TGTX Comparison
SWX vs TGTX Comparison
Compare SWX & TGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SWX
- TGTX
- Stock Information
- Founded
- SWX 1931
- TGTX 1993
- Country
- SWX United States
- TGTX United States
- Employees
- SWX N/A
- TGTX N/A
- Industry
- SWX Oil & Gas Production
- TGTX Biotechnology: Pharmaceutical Preparations
- Sector
- SWX Utilities
- TGTX Health Care
- Exchange
- SWX Nasdaq
- TGTX Nasdaq
- Market Cap
- SWX 5.1B
- TGTX 5.4B
- IPO Year
- SWX N/A
- TGTX 1995
- Fundamental
- Price
- SWX $70.35
- TGTX $31.06
- Analyst Decision
- SWX Hold
- TGTX Strong Buy
- Analyst Count
- SWX 4
- TGTX 6
- Target Price
- SWX $73.50
- TGTX $40.67
- AVG Volume (30 Days)
- SWX 318.1K
- TGTX 1.9M
- Earning Date
- SWX 02-26-2025
- TGTX 02-26-2025
- Dividend Yield
- SWX 3.54%
- TGTX N/A
- EPS Growth
- SWX N/A
- TGTX N/A
- EPS
- SWX 2.50
- TGTX N/A
- Revenue
- SWX $5,209,839,000.00
- TGTX $264,790,000.00
- Revenue This Year
- SWX N/A
- TGTX $44.11
- Revenue Next Year
- SWX $1.74
- TGTX $63.92
- P/E Ratio
- SWX $28.00
- TGTX N/A
- Revenue Growth
- SWX N/A
- TGTX 39.53
- 52 Week Low
- SWX $57.55
- TGTX $12.84
- 52 Week High
- SWX $80.29
- TGTX $36.84
- Technical
- Relative Strength Index (RSI)
- SWX 37.91
- TGTX 47.35
- Support Level
- SWX $69.47
- TGTX $29.90
- Resistance Level
- SWX $71.15
- TGTX $33.55
- Average True Range (ATR)
- SWX 1.64
- TGTX 1.78
- MACD
- SWX -0.05
- TGTX -0.37
- Stochastic Oscillator
- SWX 33.97
- TGTX 22.61
About SWX Southwest Gas Holdings Inc. (DE)
Southwest Gas Holdings Inc is a utility company engaged in the purchasing, distributing, and transporting of natural gas in the American Southwest. The company segments its activities into natural gas distribution and Utility Infrastructure Services units. The first of these encompasses the company's core natural gas business as distributors in the states of Arizona and Nevada. The natural gas distribution division is responsible for roughly half of Southwest Gas' total revenue through the sale of natural gas to mainly residential and small commercial customers. The Utility Infrastructure Services segment generates the other half of the company's total revenue from the underground piping contractor services that its subsidiary, Centuri Construction Group, provides.
About TGTX TG Therapeutics Inc.
TG Therapeutics Inc is a fully integrated, commercial-stage, biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell diseases. The company has received approval from the U.S. Food and Drug Administration (FDA) for BRIUMVI (ublituximab-xiiy) for the treatment of adult patients with relapsing forms of multiple sclerosis (RMS). and the company is developing TG-1701 (BTK inhibitor) and TG-1801 (anti-CD47/CD19 bispecific mAb) for B-cell disorders which are under Phase 1 trial.